SPIROVANT

Trademark usage description

pharmaceutical preparations for human use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions; biological preparati Read More

Vienna Information

2 . 9 . 24

Lungs (respiratory system)Poumons (appareil respiratoire)

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions; biological preparations for medical or therapeutic use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions.

Classification kind code

Class [042]
Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; research in the field of pharmaceutical and biological therapeutic products, clinical trials and post authorization research for the marketing of medicines and/or commercial post-launching of medicines; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines.

Classification kind code

Class [044]
Providing health and medical information in the fields of cystic fibrosis, and pulmonary diseases, disorders and conditions; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biologic products for the prevention and treatment of diseases, disorders and conditions.

Classification kind code

Mark Details

Serial Number

2014205

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 4^th Mar 2021	Search Recorded
Submitted for opposition 20 on 4^th Mar 2021	Examiner's First Report
Submitted for opposition 256 on 28^th Dec 2020	Notification of Possible Opposition Sent
Submitted for opposition 80 on 24^th Jun 2020	Change of Title Registered
Submitted for opposition 48 on 5^th May 2020	Agent Changed
Submitted for opposition 257 on 27^th Feb 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 26^th Feb 2020	Created
Submitted for opposition 31 on 26^th Feb 2020	Formalized
Submitted for opposition 30 on 18^th Dec 2019	Filed
Submitted for opposition 228 on 18^th Dec 2019	International Registration

SPIROVANT

Classification Information

Class [005]Pharmaceutical preparations for human use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions; biological preparations for medical or therapeutic use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions.

Classification kind code

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for human use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions; biological preparations for medical or therapeutic use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions.